OR
CDLX icon

Olympiad Research’s Cardlytics CDLX Stock Holding History

Olympiad Research’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,132
Closed -$454K – 371
2024
Q1 		$454K Buy
3,132
+455
+17% +$38.4K 0.3% 88
2023
Q4 		$247K Buy
+2,677
New +$272K 0.19% 221

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PIP
PB Investment Partners Burlingame, California $127M AUM 0.83% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BCM
Brightlight Capital Management Westport, Connecticut $101M AUM 23.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Olympiad Research's CDLX Position: Q2 2024 in Review

Olympiad Research sold out of Cardlytics (CDLX) in Q2 2024, closing a stake of 3,132 shares — an estimated $454K sold.

Olympiad Research first reported a position in CDLX in Q4 2023 and held it in 2 quarters. The position peaked at $454K in Q1 2024. 127 funds tracked by Wall St. Rank hold CDLX as of Q2 2024.

  • Olympiad Research reported no remaining Cardlytics position as of Q2 2024 after selling out during the quarter.
  • Olympiad Research sold 3,132 Cardlytics shares in Q2 2024, an estimated $454K.
  • Olympiad Research first reported a position in Cardlytics in Q4 2023 and held it in 2 quarters.
  • Olympiad Research's Cardlytics position peaked at $454K in Q1 2024.
  • 127 funds tracked by Wall St. Rank held Cardlytics as of Q2 2024.

Based on Olympiad Research's 13F filing for Q2 2024, filed 12 Aug 2024.